Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    24678979 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study
Condition: Hypercholesterolemia
Interventions: Biological: Evolocumab;   Biological: Placebo;   Drug: Atorvastatin;   Drug: Ezetimibe;   Other: Diet Only

Study has passed its completion date and status has not been verified in more than two years.